Sentence examples for diminished interaction from inspiring English sources

Recycling of the variants is reduced, due to their diminished interaction with the FcRn receptor at pH <6.5.

Interestingly, diminished interaction between CTCF and UBF was detected in cells expressing CTCFL.

(C ) Similarly diminished interaction was replicated in a co-immunoprecipitation assay.

Replacing the piperidine ring by the N,N-diisobutyl residue of piperine diminished interaction with TRPV1 receptors, enhanced potency and efficacy of IGABA modulation, diminished the higher efficacy of piperine on α3-subunit and/or β2/3-subunit containing receptors (compare Fig. 2A and B with Fig. 2D and E) and induced a γ2 subunit dependence (Fig. 2 D).

This study shows for the first time a diminished interaction between S100A1 and ryanodine receptors (RyR2s) in experimental HF.

Consistently, deleting both of the Ig1 and Ig2 domains from Robo2 results in a diminished interaction with Robo1 in vivo and in vitro.

As a consequence, diminished interactions of these miRNAs with the mRNAs of vesican, Rb1, and PTEN may occur, which in turn may relieve these mRNAs for translation.

Treatment with ABT-263 abolished or substantially diminished interactions between Bax or Bim with Bcl-2 or Bcl-xL, and very slightly reduced the association of Bax with Bcl-w.

The efficacy of paclitaxel can be attenuated by the overexpression of multidrug efflux transporters, altered metabolism, decreased sensitivity to apoptosis, alterations in microtubule dynamics, diminished interactions of paclitaxel with its cellular target, and genetic polymorphisms [ 1, 2].

It allowed diminishing interactions between the sample-solvent and protein and elimination of undesired effects such as band splitting and band broadening.

MGAH22, by diminishing interactions with this inhibitory FcγR, would be expected to exhibit additional favorable properties in the presence of mononuclear phagocytic effector cells and potentially further enhanced efficacy against low HER2-expressing tumors or tumors resistant to trastuzumab therapy.